Small Molecule Cancer Drugs Market Overall Study Report 2022-2028 | Otsuka Pharmaceutical Co. Ltd, Eli Lilly and Co
Small molecule cancer drugs is in the very early stages of development for use in the treatment of cancer. In recent years, it has been found that cancer cells secrete chemicals as a defense against cancer treatments. These chemicals can be detected by the body's immune system, and these chemicals are often found within tumors. The body's immune system recognizes some cancer cells as foreign particles that may be harmful to the body. With growing cancer burden worldwide, key pharmaceutical and biotechnology companies are focused on developing novel therapies and medications for the treatment of different types of cancer. With growing focus on small molecule cancer drugs , research and development activities are likely to surge in the near future. Hence, such factors can augment growth small molecule cancer drugs market in the near future. Recently, in November 2020, Genesis Therapeutics collaborated with Genentech for AI-driven multi-target drug discovery.